Clopidogrel Hypersensitivity: Overview of the Problem

Curr Vasc Pharmacol. 2019;17(2):108-109. doi: 10.2174/1570161116666180820123041.

Authors

Michael P Savage¹, David L Fischman²

Affiliations

¹ Department of Cardiology Sidney Kimmel Medical College at Thomas Jefferson University Director, Cardiac Catheterization Laboratory Thomas Jefferson University Hospital Philadelphia, PA, United States.
² Department of Medicine Sidney Kimmel Medical College at Thomas Jefferson University Co-Director, Cardiac Catheterization Laboratory Director, Interventional Cardiology Fellowship Program Thomas Jefferson University Hospital Philadelphia, PA, United States.

PMID: 30124153
DOI: 10.2174/1570161116666180820123041

No abstract available

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Publication types

Editorial
Introductory Journal Article

MeSH terms

Cardiovascular Diseases / blood
Cardiovascular Diseases / diagnosis
Cardiovascular Diseases / drug therapy*
Clopidogrel / adverse effects*
Drug Hypersensitivity / diagnosis
Drug Hypersensitivity / immunology*
Drug Hypersensitivity / mortality
Drug Hypersensitivity / therapy
Humans
Platelet Aggregation / drug effects
Platelet Aggregation Inhibitors / adverse effects*
Purinergic P2Y Receptor Antagonists / adverse effects*
Risk Factors
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Clopidogrel